Daiichi Sankyo Pharma Development recalls Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactur
Recalled August 6, 2014 · FDA recall D-1508-2014 · Daiichi Sankyo Pharma Development
Hazard
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping. · FDA Class II
Sold at
Nationwide
Description
Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.
Product
Benicar HCT Tablets (olmesartan medoxomil/hydrochlorothiazide) 40 mg/25 mg, 30 and 90 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-107-30 and NDC 65597-107-90
Manufacturer(s)
Daiichi Sankyo Pharma Development
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →